nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—skin cancer	0.54	1	CtDrD
Fluorouracil—ABCG2—Vismodegib—skin cancer	0.0458	0.156	CbGbCtD
Fluorouracil—ABCG2—Vemurafenib—skin cancer	0.0362	0.123	CbGbCtD
Fluorouracil—ALB—Vismodegib—skin cancer	0.0316	0.108	CbGbCtD
Fluorouracil—CYP1A2—Imiquimod—skin cancer	0.0272	0.0928	CbGbCtD
Fluorouracil—ALB—Vemurafenib—skin cancer	0.0249	0.085	CbGbCtD
Fluorouracil—CYP2C8—Vismodegib—skin cancer	0.0244	0.0831	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—skin cancer	0.024	0.0819	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—skin cancer	0.0236	0.0805	CbGbCtD
Fluorouracil—CYP2C9—Vismodegib—skin cancer	0.017	0.058	CbGbCtD
Fluorouracil—CYP1A2—Vemurafenib—skin cancer	0.0149	0.0508	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—skin cancer	0.0124	0.0423	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—skin cancer	0.0114	0.039	CbGbCtD
Fluorouracil—UMPS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.0034	0.0778	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00316	0.0723	CbGpPWpGaD
Fluorouracil—UPP1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00316	0.0723	CbGpPWpGaD
Fluorouracil—UMPS—hair follicle—skin cancer	0.00298	0.0893	CbGeAlD
Fluorouracil—PPAT—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00219	0.0501	CbGpPWpGaD
Fluorouracil—DPYD—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00219	0.0501	CbGpPWpGaD
Fluorouracil—TYMP—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00156	0.0357	CbGpPWpGaD
Fluorouracil—UPP2—head—skin cancer	0.00149	0.0446	CbGeAlD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00135	0.031	CbGpPWpGaD
Fluorouracil—TYMP—endothelium—skin cancer	0.00131	0.0392	CbGeAlD
Fluorouracil—PPAT—nipple—skin cancer	0.0013	0.039	CbGeAlD
Fluorouracil—TYMP—blood vessel—skin cancer	0.00121	0.0361	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.0012	0.0274	CbGpPWpGaD
Fluorouracil—UPP1—skin of body—skin cancer	0.00119	0.0356	CbGeAlD
Fluorouracil—MTHFR—blood vessel—skin cancer	0.00113	0.034	CbGeAlD
Fluorouracil—UPP1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00111	0.0255	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00111	0.0255	CbGpPWpGaD
Fluorouracil—UPP1—mammalian vulva—skin cancer	0.00108	0.0324	CbGeAlD
Fluorouracil—ABCC5—hair follicle—skin cancer	0.00108	0.0323	CbGeAlD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00103	0.0236	CbGpPWpGaD
Fluorouracil—UMPS—female reproductive system—skin cancer	0.00101	0.0303	CbGeAlD
Fluorouracil—TYMS—Sorafenib—Vismodegib—skin cancer	0.000959	0.584	CbGdCrCtD
Fluorouracil—UPP1—female reproductive system—skin cancer	0.000928	0.0278	CbGeAlD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000896	0.0205	CbGpPWpGaD
Fluorouracil—TYMP—nipple—skin cancer	0.000873	0.0261	CbGeAlD
Fluorouracil—UMPS—head—skin cancer	0.000845	0.0253	CbGeAlD
Fluorouracil—MTHFR—neck—skin cancer	0.000812	0.0243	CbGeAlD
Fluorouracil—TYMS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000798	0.0183	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000771	0.0176	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000771	0.0176	CbGpPWpGaD
Fluorouracil—DPYD—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000771	0.0176	CbGpPWpGaD
Fluorouracil—PPAT—mammalian vulva—skin cancer	0.000761	0.0228	CbGeAlD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—skin cancer	0.000684	0.416	CbGdCrCtD
Fluorouracil—SLC29A1—nipple—skin cancer	0.000671	0.0201	CbGeAlD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000661	0.0151	CbGpPWpGaD
Fluorouracil—PPAT—female reproductive system—skin cancer	0.000652	0.0195	CbGeAlD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000621	0.0142	CbGpPWpGaD
Fluorouracil—TYMP—connective tissue—skin cancer	0.000619	0.0185	CbGeAlD
Fluorouracil—UMPS—lymph node—skin cancer	0.000592	0.0177	CbGeAlD
Fluorouracil—TYMP—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000549	0.0126	CbGpPWpGaD
Fluorouracil—PPAT—head—skin cancer	0.000545	0.0163	CbGeAlD
Fluorouracil—UPP1—lymph node—skin cancer	0.000543	0.0163	CbGeAlD
Fluorouracil—TYMS—connective tissue—skin cancer	0.000531	0.0159	CbGeAlD
Fluorouracil—TYMP—mammalian vulva—skin cancer	0.00051	0.0153	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—CDK4—skin cancer	0.000484	0.0111	CbGpPWpGaD
Fluorouracil—TYMS—skin of body—skin cancer	0.000479	0.0144	CbGeAlD
Fluorouracil—SLC29A1—connective tissue—skin cancer	0.000476	0.0143	CbGeAlD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000476	0.0109	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000455	0.0104	CbGpPWpGaD
Fluorouracil—TYMP—lymphoid tissue—skin cancer	0.000453	0.0136	CbGeAlD
Fluorouracil—DPYD—lymph node—skin cancer	0.000441	0.0132	CbGeAlD
Fluorouracil—TYMS—mammalian vulva—skin cancer	0.000437	0.0131	CbGeAlD
Fluorouracil—TYMP—female reproductive system—skin cancer	0.000436	0.0131	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—BRAF—skin cancer	0.000428	0.00981	CbGpPWpGaD
Fluorouracil—UMPS—Fluoropyrimidine Activity—TP53—skin cancer	0.000427	0.00977	CbGpPWpGaD
Fluorouracil—MTHFR—lymphoid tissue—skin cancer	0.000425	0.0127	CbGeAlD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000414	0.00948	CbGpPWpGaD
Fluorouracil—MTHFR—female reproductive system—skin cancer	0.00041	0.0123	CbGeAlD
Fluorouracil—UPP1—Fluoropyrimidine Activity—TP53—skin cancer	0.000397	0.00908	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—TP53—skin cancer	0.000397	0.00908	CbGpPWpGaD
Fluorouracil—SLC29A1—mammalian vulva—skin cancer	0.000392	0.0117	CbGeAlD
Fluorouracil—TYMS—lymphoid tissue—skin cancer	0.000388	0.0116	CbGeAlD
Fluorouracil—PPAT—lymph node—skin cancer	0.000381	0.0114	CbGeAlD
Fluorouracil—TYMS—female reproductive system—skin cancer	0.000374	0.0112	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—CDKN2A—skin cancer	0.00037	0.00848	CbGpPWpGaD
Fluorouracil—TYMP—head—skin cancer	0.000365	0.0109	CbGeAlD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000362	0.00829	CbGpPWpGaD
Fluorouracil—SLC29A1—lymphoid tissue—skin cancer	0.000348	0.0104	CbGeAlD
Fluorouracil—CYP1A2—nipple—skin cancer	0.000344	0.0103	CbGeAlD
Fluorouracil—MTHFR—head—skin cancer	0.000343	0.0103	CbGeAlD
Fluorouracil—SLC29A1—female reproductive system—skin cancer	0.000336	0.0101	CbGeAlD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000315	0.00722	CbGpPWpGaD
Fluorouracil—TYMS—head—skin cancer	0.000313	0.00937	CbGeAlD
Fluorouracil—TYMS—E2F transcription factor network—XRCC1—skin cancer	0.000307	0.00704	CbGpPWpGaD
Fluorouracil—ABCC3—female reproductive system—skin cancer	0.000307	0.0092	CbGeAlD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000289	0.00662	CbGpPWpGaD
Fluorouracil—ABCC5—Defective B3GAT3 causes JDSSDHD—CSPG4—skin cancer	0.000286	0.00655	CbGpPWpGaD
Fluorouracil—TYMS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000281	0.00643	CbGpPWpGaD
Fluorouracil—SLC29A1—head—skin cancer	0.000281	0.0084	CbGeAlD
Fluorouracil—DPYD—Fluoropyrimidine Activity—TP53—skin cancer	0.000275	0.0063	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—TP53—skin cancer	0.000275	0.0063	CbGpPWpGaD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000272	0.00623	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000271	0.00621	CbGpPWpGaD
Fluorouracil—ABCC3—head—skin cancer	0.000257	0.00768	CbGeAlD
Fluorouracil—TYMP—lymph node—skin cancer	0.000255	0.00765	CbGeAlD
Fluorouracil—ABCC4—female reproductive system—skin cancer	0.000254	0.00759	CbGeAlD
Fluorouracil—Rhinitis—Imiquimod—skin cancer	0.000252	0.00287	CcSEcCtD
Fluorouracil—Thrombophlebitis—Temozolomide—skin cancer	0.000252	0.00286	CcSEcCtD
Fluorouracil—Haemorrhage—Imiquimod—skin cancer	0.000252	0.00286	CcSEcCtD
Fluorouracil—Pharyngitis—Imiquimod—skin cancer	0.00025	0.00284	CcSEcCtD
Fluorouracil—Myocardial ischaemia—Docetaxel—skin cancer	0.000248	0.00282	CcSEcCtD
Fluorouracil—Lethargy—Dactinomycin—skin cancer	0.000246	0.00279	CcSEcCtD
Fluorouracil—MTHFR—lymph node—skin cancer	0.00024	0.00719	CbGeAlD
Fluorouracil—Pruritus—Vismodegib—skin cancer	0.00024	0.00273	CcSEcCtD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.000234	0.00536	CbGpPWpGaD
Fluorouracil—Eye irritation—Docetaxel—skin cancer	0.000234	0.00266	CcSEcCtD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000232	0.00532	CbGpPWpGaD
Fluorouracil—Diarrhoea—Vismodegib—skin cancer	0.000232	0.00264	CcSEcCtD
Fluorouracil—Amnesia—Temozolomide—skin cancer	0.000232	0.00264	CcSEcCtD
Fluorouracil—Extravasation—Docetaxel—skin cancer	0.000229	0.0026	CcSEcCtD
Fluorouracil—Arrhythmia—Imiquimod—skin cancer	0.000225	0.00255	CcSEcCtD
Fluorouracil—Alopecia—Imiquimod—skin cancer	0.000222	0.00253	CcSEcCtD
Fluorouracil—TYMS—lymph node—skin cancer	0.000219	0.00656	CbGeAlD
Fluorouracil—Erythema—Imiquimod—skin cancer	0.000219	0.00249	CcSEcCtD
Fluorouracil—Myalgia—Vemurafenib—skin cancer	0.000219	0.00248	CcSEcCtD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000219	0.005	CbGpPWpGaD
Fluorouracil—Lacrimation increased—Docetaxel—skin cancer	0.000217	0.00246	CcSEcCtD
Fluorouracil—Vomiting—Vismodegib—skin cancer	0.000216	0.00245	CcSEcCtD
Fluorouracil—ABCC5—lymph node—skin cancer	0.000214	0.00641	CbGeAlD
Fluorouracil—Rash—Vismodegib—skin cancer	0.000214	0.00243	CcSEcCtD
Fluorouracil—Dermatitis—Vismodegib—skin cancer	0.000214	0.00243	CcSEcCtD
Fluorouracil—Pancytopenia—Bleomycin—skin cancer	0.000212	0.00241	CcSEcCtD
Fluorouracil—ABCC4—head—skin cancer	0.000212	0.00634	CbGeAlD
Fluorouracil—Anaphylactic shock—Vemurafenib—skin cancer	0.00021	0.00238	CcSEcCtD
Fluorouracil—ABCG2—mammalian vulva—skin cancer	0.000209	0.00626	CbGeAlD
Fluorouracil—Dysphagia—Dactinomycin—skin cancer	0.000208	0.00237	CcSEcCtD
Fluorouracil—Infection—Vemurafenib—skin cancer	0.000208	0.00237	CcSEcCtD
Fluorouracil—TYMP—Bladder Cancer—TP53—skin cancer	0.000206	0.00472	CbGpPWpGaD
Fluorouracil—Inflammation—Docetaxel—skin cancer	0.000206	0.00234	CcSEcCtD
Fluorouracil—Nervous system disorder—Vemurafenib—skin cancer	0.000206	0.00234	CcSEcCtD
Fluorouracil—Ataxia—Temozolomide—skin cancer	0.000205	0.00233	CcSEcCtD
Fluorouracil—Nausea—Vismodegib—skin cancer	0.000201	0.00229	CcSEcCtD
Fluorouracil—Pneumonia—Bleomycin—skin cancer	0.0002	0.00228	CcSEcCtD
Fluorouracil—Dry skin—Temozolomide—skin cancer	0.0002	0.00227	CcSEcCtD
Fluorouracil—Pancytopenia—Dactinomycin—skin cancer	0.000198	0.00225	CcSEcCtD
Fluorouracil—TYMS—Circadian rythm related genes—NKX2-1—skin cancer	0.000197	0.00451	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—HRAS—skin cancer	0.000197	0.00451	CbGpPWpGaD
Fluorouracil—SLC29A1—lymph node—skin cancer	0.000196	0.00588	CbGeAlD
Fluorouracil—Acute coronary syndrome—Bleomycin—skin cancer	0.000196	0.00223	CcSEcCtD
Fluorouracil—TYMP—Fluoropyrimidine Activity—TP53—skin cancer	0.000196	0.00449	CbGpPWpGaD
Fluorouracil—Hypotension—Vemurafenib—skin cancer	0.000196	0.00223	CcSEcCtD
Fluorouracil—Myocardial infarction—Bleomycin—skin cancer	0.000195	0.00222	CcSEcCtD
Fluorouracil—Stomatitis—Bleomycin—skin cancer	0.000194	0.00221	CcSEcCtD
Fluorouracil—Muscular weakness—Temozolomide—skin cancer	0.000192	0.00218	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000191	0.00217	CcSEcCtD
Fluorouracil—Convulsion—Imiquimod—skin cancer	0.00019	0.00216	CcSEcCtD
Fluorouracil—Dysphagia—Temozolomide—skin cancer	0.000188	0.00214	CcSEcCtD
Fluorouracil—Pneumonia—Dactinomycin—skin cancer	0.000187	0.00212	CcSEcCtD
Fluorouracil—Myalgia—Imiquimod—skin cancer	0.000186	0.00212	CcSEcCtD
Fluorouracil—Chest pain—Imiquimod—skin cancer	0.000186	0.00212	CcSEcCtD
Fluorouracil—Discomfort—Imiquimod—skin cancer	0.000184	0.00209	CcSEcCtD
Fluorouracil—CYP2C8—female reproductive system—skin cancer	0.000184	0.00551	CbGeAlD
Fluorouracil—Oesophagitis—Docetaxel—skin cancer	0.000182	0.00207	CcSEcCtD
Fluorouracil—Decreased appetite—Vemurafenib—skin cancer	0.000182	0.00207	CcSEcCtD
Fluorouracil—Stomatitis—Dactinomycin—skin cancer	0.000181	0.00206	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000181	0.00206	CcSEcCtD
Fluorouracil—ABCC3—lymph node—skin cancer	0.00018	0.00538	CbGeAlD
Fluorouracil—Haemoglobin—Bleomycin—skin cancer	0.00018	0.00204	CcSEcCtD
Fluorouracil—Pancytopenia—Temozolomide—skin cancer	0.000179	0.00203	CcSEcCtD
Fluorouracil—Oedema—Imiquimod—skin cancer	0.000179	0.00203	CcSEcCtD
Fluorouracil—Haemorrhage—Bleomycin—skin cancer	0.000179	0.00203	CcSEcCtD
Fluorouracil—Hypoaesthesia—Bleomycin—skin cancer	0.000178	0.00202	CcSEcCtD
Fluorouracil—Infection—Imiquimod—skin cancer	0.000178	0.00202	CcSEcCtD
Fluorouracil—Nervous system disorder—Imiquimod—skin cancer	0.000175	0.00199	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Temozolomide—skin cancer	0.000175	0.00199	CcSEcCtD
Fluorouracil—Tachycardia—Imiquimod—skin cancer	0.000174	0.00198	CcSEcCtD
Fluorouracil—Agranulocytosis—Dactinomycin—skin cancer	0.000173	0.00197	CcSEcCtD
Fluorouracil—Sepsis—Docetaxel—skin cancer	0.000173	0.00197	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Temozolomide—skin cancer	0.000172	0.00195	CcSEcCtD
Fluorouracil—UMPS—Metabolism—PLIN2—skin cancer	0.000171	0.00393	CbGpPWpGaD
Fluorouracil—Anorexia—Imiquimod—skin cancer	0.00017	0.00194	CcSEcCtD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—TP53—skin cancer	0.00017	0.00389	CbGpPWpGaD
Fluorouracil—Pneumonia—Temozolomide—skin cancer	0.000169	0.00192	CcSEcCtD
Fluorouracil—Infestation NOS—Temozolomide—skin cancer	0.000168	0.00191	CcSEcCtD
Fluorouracil—Infestation—Temozolomide—skin cancer	0.000168	0.00191	CcSEcCtD
Fluorouracil—Thrombophlebitis—Docetaxel—skin cancer	0.000167	0.0019	CcSEcCtD
Fluorouracil—Body temperature increased—Vemurafenib—skin cancer	0.000166	0.00188	CcSEcCtD
Fluorouracil—Pharyngitis—Dactinomycin—skin cancer	0.000165	0.00188	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Temozolomide—skin cancer	0.000165	0.00187	CcSEcCtD
Fluorouracil—Swelling—Docetaxel—skin cancer	0.000164	0.00187	CcSEcCtD
Fluorouracil—Stomatitis—Temozolomide—skin cancer	0.000164	0.00186	CcSEcCtD
Fluorouracil—CYP2C9—female reproductive system—skin cancer	0.000163	0.0049	CbGeAlD
Fluorouracil—Urinary tract infection—Temozolomide—skin cancer	0.000163	0.00186	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000163	0.00185	CcSEcCtD
Fluorouracil—Insomnia—Imiquimod—skin cancer	0.000162	0.00184	CcSEcCtD
Fluorouracil—Paraesthesia—Imiquimod—skin cancer	0.00016	0.00182	CcSEcCtD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00016	0.00367	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PLIN2—skin cancer	0.000159	0.00365	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PLIN2—skin cancer	0.000159	0.00365	CbGpPWpGaD
Fluorouracil—Dyspnoea—Imiquimod—skin cancer	0.000159	0.00181	CcSEcCtD
Fluorouracil—Somnolence—Imiquimod—skin cancer	0.000159	0.00181	CcSEcCtD
Fluorouracil—Alopecia—Bleomycin—skin cancer	0.000158	0.00179	CcSEcCtD
Fluorouracil—Sinusitis—Temozolomide—skin cancer	0.000158	0.00179	CcSEcCtD
Fluorouracil—Dyspepsia—Imiquimod—skin cancer	0.000157	0.00179	CcSEcCtD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	0.000156	0.00357	CbGpPWpGaD
Fluorouracil—Erythema—Bleomycin—skin cancer	0.000156	0.00177	CcSEcCtD
Fluorouracil—Decreased appetite—Imiquimod—skin cancer	0.000155	0.00177	CcSEcCtD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000155	0.00355	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Vemurafenib—skin cancer	0.000154	0.00175	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Imiquimod—skin cancer	0.000154	0.00175	CcSEcCtD
Fluorouracil—ABCC5—Carbohydrate metabolism—CSPG4—skin cancer	0.000154	0.00352	CbGpPWpGaD
Fluorouracil—ALB—lymph node—skin cancer	0.000153	0.00459	CbGeAlD
Fluorouracil—Pain—Imiquimod—skin cancer	0.000153	0.00174	CcSEcCtD
Fluorouracil—Dermatitis bullous—Docetaxel—skin cancer	0.000152	0.00172	CcSEcCtD
Fluorouracil—Haemoglobin—Temozolomide—skin cancer	0.000152	0.00172	CcSEcCtD
Fluorouracil—Haemorrhage—Temozolomide—skin cancer	0.000151	0.00171	CcSEcCtD
Fluorouracil—Hypoaesthesia—Temozolomide—skin cancer	0.00015	0.0017	CcSEcCtD
Fluorouracil—Pharyngitis—Temozolomide—skin cancer	0.00015	0.0017	CcSEcCtD
Fluorouracil—Cardiac failure—Docetaxel—skin cancer	0.000148	0.00169	CcSEcCtD
Fluorouracil—ABCC4—lymph node—skin cancer	0.000148	0.00444	CbGeAlD
Fluorouracil—Pruritus—Vemurafenib—skin cancer	0.000148	0.00169	CcSEcCtD
Fluorouracil—Lethargy—Docetaxel—skin cancer	0.000148	0.00168	CcSEcCtD
Fluorouracil—Alopecia—Dactinomycin—skin cancer	0.000147	0.00167	CcSEcCtD
Fluorouracil—Feeling abnormal—Imiquimod—skin cancer	0.000147	0.00167	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000146	0.00333	CbGpPWpGaD
Fluorouracil—Erythema—Dactinomycin—skin cancer	0.000145	0.00165	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000145	0.00165	CcSEcCtD
Fluorouracil—Anaemia—Bleomycin—skin cancer	0.000144	0.00163	CcSEcCtD
Fluorouracil—Diarrhoea—Vemurafenib—skin cancer	0.000143	0.00163	CcSEcCtD
Fluorouracil—Urticaria—Imiquimod—skin cancer	0.000142	0.00161	CcSEcCtD
Fluorouracil—Body temperature increased—Imiquimod—skin cancer	0.000141	0.00161	CcSEcCtD
Fluorouracil—Leukopenia—Bleomycin—skin cancer	0.000139	0.00158	CcSEcCtD
Fluorouracil—Dizziness—Vemurafenib—skin cancer	0.000139	0.00157	CcSEcCtD
Fluorouracil—UMPS—Metabolism—CSPG4—skin cancer	0.000138	0.00317	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000138	0.00316	CbGpPWpGaD
Fluorouracil—Ataxia—Docetaxel—skin cancer	0.000136	0.00155	CcSEcCtD
Fluorouracil—Anaemia—Dactinomycin—skin cancer	0.000134	0.00152	CcSEcCtD
Fluorouracil—Vomiting—Vemurafenib—skin cancer	0.000133	0.00151	CcSEcCtD
Fluorouracil—Alopecia—Temozolomide—skin cancer	0.000133	0.00151	CcSEcCtD
Fluorouracil—Dry skin—Docetaxel—skin cancer	0.000133	0.00151	CcSEcCtD
Fluorouracil—Chest pain—Bleomycin—skin cancer	0.000132	0.00151	CcSEcCtD
Fluorouracil—Myalgia—Bleomycin—skin cancer	0.000132	0.00151	CcSEcCtD
Fluorouracil—Rash—Vemurafenib—skin cancer	0.000132	0.0015	CcSEcCtD
Fluorouracil—Dermatitis—Vemurafenib—skin cancer	0.000132	0.0015	CcSEcCtD
Fluorouracil—Hypersensitivity—Imiquimod—skin cancer	0.000132	0.0015	CcSEcCtD
Fluorouracil—Headache—Vemurafenib—skin cancer	0.000131	0.00149	CcSEcCtD
Fluorouracil—Erythema—Temozolomide—skin cancer	0.000131	0.00149	CcSEcCtD
Fluorouracil—Discomfort—Bleomycin—skin cancer	0.000131	0.00149	CcSEcCtD
Fluorouracil—Leukopenia—Dactinomycin—skin cancer	0.00013	0.00148	CcSEcCtD
Fluorouracil—Nasopharyngitis—Docetaxel—skin cancer	0.00013	0.00147	CcSEcCtD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—TP53—skin cancer	0.000129	0.00296	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CSPG4—skin cancer	0.000129	0.00294	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CSPG4—skin cancer	0.000129	0.00294	CbGpPWpGaD
Fluorouracil—Confusional state—Bleomycin—skin cancer	0.000128	0.00145	CcSEcCtD
Fluorouracil—Anaphylactic shock—Bleomycin—skin cancer	0.000127	0.00144	CcSEcCtD
Fluorouracil—Oedema—Bleomycin—skin cancer	0.000127	0.00144	CcSEcCtD
Fluorouracil—Pruritus—Imiquimod—skin cancer	0.000126	0.00144	CcSEcCtD
Fluorouracil—Infection—Bleomycin—skin cancer	0.000126	0.00143	CcSEcCtD
Fluorouracil—Dysphagia—Docetaxel—skin cancer	0.000125	0.00142	CcSEcCtD
Fluorouracil—Nausea—Vemurafenib—skin cancer	0.000124	0.00141	CcSEcCtD
Fluorouracil—Thrombocytopenia—Bleomycin—skin cancer	0.000124	0.00141	CcSEcCtD
Fluorouracil—Vision blurred—Temozolomide—skin cancer	0.000124	0.00141	CcSEcCtD
Fluorouracil—Myalgia—Dactinomycin—skin cancer	0.000124	0.0014	CcSEcCtD
Fluorouracil—Diarrhoea—Imiquimod—skin cancer	0.000122	0.00139	CcSEcCtD
Fluorouracil—Discomfort—Dactinomycin—skin cancer	0.000122	0.00139	CcSEcCtD
Fluorouracil—Angina pectoris—Docetaxel—skin cancer	0.000122	0.00139	CcSEcCtD
Fluorouracil—Anaemia—Temozolomide—skin cancer	0.000121	0.00138	CcSEcCtD
Fluorouracil—Anorexia—Bleomycin—skin cancer	0.000121	0.00138	CcSEcCtD
Fluorouracil—ABCC4—Ectoderm Differentiation—SHH—skin cancer	0.00012	0.00274	CbGpPWpGaD
Fluorouracil—Pancytopenia—Docetaxel—skin cancer	0.000119	0.00135	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000119	0.00272	CbGpPWpGaD
Fluorouracil—Hypotension—Bleomycin—skin cancer	0.000119	0.00135	CcSEcCtD
Fluorouracil—Oedema—Dactinomycin—skin cancer	0.000118	0.00135	CcSEcCtD
Fluorouracil—Dizziness—Imiquimod—skin cancer	0.000118	0.00134	CcSEcCtD
Fluorouracil—Infection—Dactinomycin—skin cancer	0.000118	0.00134	CcSEcCtD
Fluorouracil—Leukopenia—Temozolomide—skin cancer	0.000117	0.00133	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dactinomycin—skin cancer	0.000116	0.00132	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000116	0.00131	CcSEcCtD
Fluorouracil—Paraesthesia—Bleomycin—skin cancer	0.000114	0.0013	CcSEcCtD
Fluorouracil—Convulsion—Temozolomide—skin cancer	0.000114	0.00129	CcSEcCtD
Fluorouracil—Vomiting—Imiquimod—skin cancer	0.000114	0.00129	CcSEcCtD
Fluorouracil—Dyspnoea—Bleomycin—skin cancer	0.000113	0.00129	CcSEcCtD
Fluorouracil—Anorexia—Dactinomycin—skin cancer	0.000113	0.00128	CcSEcCtD
Fluorouracil—Rash—Imiquimod—skin cancer	0.000113	0.00128	CcSEcCtD
Fluorouracil—Dermatitis—Imiquimod—skin cancer	0.000113	0.00128	CcSEcCtD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—TP53—skin cancer	0.000113	0.00258	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000113	0.00258	CbGpPWpGaD
Fluorouracil—Pneumonia—Docetaxel—skin cancer	0.000112	0.00128	CcSEcCtD
Fluorouracil—Headache—Imiquimod—skin cancer	0.000112	0.00127	CcSEcCtD
Fluorouracil—Myalgia—Temozolomide—skin cancer	0.000112	0.00127	CcSEcCtD
Fluorouracil—Infestation NOS—Docetaxel—skin cancer	0.000112	0.00127	CcSEcCtD
Fluorouracil—Infestation—Docetaxel—skin cancer	0.000112	0.00127	CcSEcCtD
Fluorouracil—DPYD—Metabolism—PLIN2—skin cancer	0.000111	0.00253	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PLIN2—skin cancer	0.000111	0.00253	CbGpPWpGaD
Fluorouracil—Discomfort—Temozolomide—skin cancer	0.00011	0.00125	CcSEcCtD
Fluorouracil—Decreased appetite—Bleomycin—skin cancer	0.00011	0.00125	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Docetaxel—skin cancer	0.00011	0.00125	CcSEcCtD
Fluorouracil—Myocardial infarction—Docetaxel—skin cancer	0.000109	0.00124	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Docetaxel—skin cancer	0.000109	0.00124	CcSEcCtD
Fluorouracil—Stomatitis—Docetaxel—skin cancer	0.000109	0.00124	CcSEcCtD
Fluorouracil—Pain—Bleomycin—skin cancer	0.000109	0.00123	CcSEcCtD
Fluorouracil—Conjunctivitis—Docetaxel—skin cancer	0.000109	0.00123	CcSEcCtD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	0.000108	0.00248	CbGpPWpGaD
Fluorouracil—Confusional state—Temozolomide—skin cancer	0.000108	0.00123	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000108	0.00123	CcSEcCtD
Fluorouracil—Anaphylactic shock—Temozolomide—skin cancer	0.000107	0.00122	CcSEcCtD
Fluorouracil—Oedema—Temozolomide—skin cancer	0.000107	0.00122	CcSEcCtD
Fluorouracil—Infection—Temozolomide—skin cancer	0.000106	0.00121	CcSEcCtD
Fluorouracil—Nausea—Imiquimod—skin cancer	0.000106	0.00121	CcSEcCtD
Fluorouracil—Epistaxis—Docetaxel—skin cancer	0.000105	0.0012	CcSEcCtD
Fluorouracil—Nervous system disorder—Temozolomide—skin cancer	0.000105	0.00119	CcSEcCtD
Fluorouracil—Thrombocytopenia—Temozolomide—skin cancer	0.000105	0.00119	CcSEcCtD
Fluorouracil—ABCG2—lymph node—skin cancer	0.000105	0.00314	CbGeAlD
Fluorouracil—Feeling abnormal—Bleomycin—skin cancer	0.000105	0.00119	CcSEcCtD
Fluorouracil—ABCC5—Carbohydrate metabolism—ENO2—skin cancer	0.000104	0.00239	CbGpPWpGaD
Fluorouracil—Agranulocytosis—Docetaxel—skin cancer	0.000104	0.00118	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—skin cancer	0.000103	0.00117	CcSEcCtD
Fluorouracil—Anorexia—Temozolomide—skin cancer	0.000102	0.00116	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—skin cancer	0.000101	0.00115	CcSEcCtD
Fluorouracil—Urticaria—Bleomycin—skin cancer	0.000101	0.00115	CcSEcCtD
Fluorouracil—Haemoglobin—Docetaxel—skin cancer	0.000101	0.00115	CcSEcCtD
Fluorouracil—Rhinitis—Docetaxel—skin cancer	0.000101	0.00114	CcSEcCtD
Fluorouracil—Body temperature increased—Bleomycin—skin cancer	0.0001	0.00114	CcSEcCtD
Fluorouracil—Haemorrhage—Docetaxel—skin cancer	0.0001	0.00114	CcSEcCtD
Fluorouracil—TYMS—Fluoropyrimidine Activity—TP53—skin cancer	0.0001	0.0023	CbGpPWpGaD
Fluorouracil—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	0.0001	0.00229	CbGpPWpGaD
Fluorouracil—Hypoaesthesia—Docetaxel—skin cancer	9.97e-05	0.00113	CcSEcCtD
Fluorouracil—Pharyngitis—Docetaxel—skin cancer	9.95e-05	0.00113	CcSEcCtD
Fluorouracil—MTHFR—Selenium Micronutrient Network—PTGS2—skin cancer	9.91e-05	0.00227	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Dactinomycin—skin cancer	9.76e-05	0.00111	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Temozolomide—skin cancer	9.76e-05	0.00111	CcSEcCtD
Fluorouracil—Insomnia—Temozolomide—skin cancer	9.69e-05	0.0011	CcSEcCtD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—TP53—skin cancer	9.68e-05	0.00222	CbGpPWpGaD
Fluorouracil—Paraesthesia—Temozolomide—skin cancer	9.62e-05	0.00109	CcSEcCtD
Fluorouracil—Dyspnoea—Temozolomide—skin cancer	9.55e-05	0.00109	CcSEcCtD
Fluorouracil—TYMS—E2F transcription factor network—CDKN2A—skin cancer	9.54e-05	0.00219	CbGpPWpGaD
Fluorouracil—Somnolence—Temozolomide—skin cancer	9.52e-05	0.00108	CcSEcCtD
Fluorouracil—Dyspepsia—Temozolomide—skin cancer	9.43e-05	0.00107	CcSEcCtD
Fluorouracil—UMPS—Metabolism—ENO2—skin cancer	9.4e-05	0.00215	CbGpPWpGaD
Fluorouracil—Body temperature increased—Dactinomycin—skin cancer	9.36e-05	0.00106	CcSEcCtD
Fluorouracil—Hypersensitivity—Bleomycin—skin cancer	9.35e-05	0.00106	CcSEcCtD
Fluorouracil—Decreased appetite—Temozolomide—skin cancer	9.31e-05	0.00106	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Temozolomide—skin cancer	9.25e-05	0.00105	CcSEcCtD
Fluorouracil—Pain—Temozolomide—skin cancer	9.16e-05	0.00104	CcSEcCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.15e-05	0.0021	CbGpPWpGaD
Fluorouracil—Pruritus—Bleomycin—skin cancer	8.98e-05	0.00102	CcSEcCtD
Fluorouracil—Arrhythmia—Docetaxel—skin cancer	8.96e-05	0.00102	CcSEcCtD
Fluorouracil—PPAT—Metabolism—CSPG4—skin cancer	8.91e-05	0.00204	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CSPG4—skin cancer	8.91e-05	0.00204	CbGpPWpGaD
Fluorouracil—Alopecia—Docetaxel—skin cancer	8.86e-05	0.00101	CcSEcCtD
Fluorouracil—Feeling abnormal—Temozolomide—skin cancer	8.83e-05	0.001	CcSEcCtD
Fluorouracil—UPP1—Metabolism—ENO2—skin cancer	8.74e-05	0.002	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ENO2—skin cancer	8.74e-05	0.002	CbGpPWpGaD
Fluorouracil—Erythema—Docetaxel—skin cancer	8.73e-05	0.000992	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—skin cancer	8.72e-05	0.000991	CcSEcCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	8.63e-05	0.00198	CbGpPWpGaD
Fluorouracil—Urticaria—Temozolomide—skin cancer	8.51e-05	0.000967	CcSEcCtD
Fluorouracil—Body temperature increased—Temozolomide—skin cancer	8.47e-05	0.000962	CcSEcCtD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—IL6—skin cancer	8.35e-05	0.00191	CbGpPWpGaD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—TP53—skin cancer	8.3e-05	0.0019	CbGpPWpGaD
Fluorouracil—Diarrhoea—Dactinomycin—skin cancer	8.1e-05	0.000921	CcSEcCtD
Fluorouracil—Vomiting—Bleomycin—skin cancer	8.07e-05	0.000917	CcSEcCtD
Fluorouracil—Anaemia—Docetaxel—skin cancer	8.07e-05	0.000917	CcSEcCtD
Fluorouracil—Rash—Bleomycin—skin cancer	8.01e-05	0.00091	CcSEcCtD
Fluorouracil—Dermatitis—Bleomycin—skin cancer	8e-05	0.000909	CcSEcCtD
Fluorouracil—Hypersensitivity—Temozolomide—skin cancer	7.89e-05	0.000897	CcSEcCtD
Fluorouracil—TYMP—Metabolism—PLIN2—skin cancer	7.87e-05	0.0018	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.87e-05	0.0018	CbGpPWpGaD
Fluorouracil—Leukopenia—Docetaxel—skin cancer	7.81e-05	0.000888	CcSEcCtD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—skin cancer	7.8e-05	0.00179	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDK4—skin cancer	7.63e-05	0.00175	CbGpPWpGaD
Fluorouracil—Pruritus—Temozolomide—skin cancer	7.58e-05	0.000861	CcSEcCtD
Fluorouracil—Convulsion—Docetaxel—skin cancer	7.56e-05	0.000859	CcSEcCtD
Fluorouracil—Nausea—Bleomycin—skin cancer	7.54e-05	0.000857	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—skin cancer	7.53e-05	0.000856	CcSEcCtD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.49e-05	0.00171	CbGpPWpGaD
Fluorouracil—Rash—Dactinomycin—skin cancer	7.47e-05	0.000849	CcSEcCtD
Fluorouracil—Chest pain—Docetaxel—skin cancer	7.43e-05	0.000844	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—skin cancer	7.43e-05	0.000844	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—TP53—skin cancer	7.42e-05	0.0017	CbGpPWpGaD
Fluorouracil—Diarrhoea—Temozolomide—skin cancer	7.33e-05	0.000833	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—skin cancer	7.18e-05	0.000816	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—skin cancer	7.12e-05	0.000809	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—skin cancer	7.12e-05	0.000809	CcSEcCtD
Fluorouracil—Dizziness—Temozolomide—skin cancer	7.08e-05	0.000805	CcSEcCtD
Fluorouracil—Infection—Docetaxel—skin cancer	7.08e-05	0.000804	CcSEcCtD
Fluorouracil—Nausea—Dactinomycin—skin cancer	7.03e-05	0.000799	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—skin cancer	6.98e-05	0.000794	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—skin cancer	6.97e-05	0.000793	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—skin cancer	6.95e-05	0.00079	CcSEcCtD
Fluorouracil—Vomiting—Temozolomide—skin cancer	6.81e-05	0.000774	CcSEcCtD
Fluorouracil—MTHFR—Folate Metabolism—IL6—skin cancer	6.8e-05	0.00156	CbGpPWpGaD
Fluorouracil—Anorexia—Docetaxel—skin cancer	6.79e-05	0.000772	CcSEcCtD
Fluorouracil—Rash—Temozolomide—skin cancer	6.75e-05	0.000767	CcSEcCtD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.75e-05	0.00155	CbGpPWpGaD
Fluorouracil—Dermatitis—Temozolomide—skin cancer	6.75e-05	0.000767	CcSEcCtD
Fluorouracil—Headache—Temozolomide—skin cancer	6.71e-05	0.000763	CcSEcCtD
Fluorouracil—Hypotension—Docetaxel—skin cancer	6.66e-05	0.000756	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—skin cancer	6.49e-05	0.000737	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—skin cancer	6.44e-05	0.000732	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—skin cancer	6.4e-05	0.000727	CcSEcCtD
Fluorouracil—Nausea—Temozolomide—skin cancer	6.36e-05	0.000723	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—skin cancer	6.35e-05	0.000722	CcSEcCtD
Fluorouracil—TYMP—Metabolism—CSPG4—skin cancer	6.35e-05	0.00145	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.35e-05	0.00145	CbGpPWpGaD
Fluorouracil—Somnolence—Docetaxel—skin cancer	6.33e-05	0.00072	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—skin cancer	6.27e-05	0.000713	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—skin cancer	6.19e-05	0.000704	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—skin cancer	6.15e-05	0.000699	CcSEcCtD
Fluorouracil—Pain—Docetaxel—skin cancer	6.09e-05	0.000692	CcSEcCtD
Fluorouracil—DPYD—Metabolism—ENO2—skin cancer	6.06e-05	0.00139	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ENO2—skin cancer	6.06e-05	0.00139	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Docetaxel—skin cancer	5.87e-05	0.000667	CcSEcCtD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDKN2A—skin cancer	5.84e-05	0.00134	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	5.78e-05	0.00132	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	5.72e-05	0.00131	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.65e-05	0.00129	CbGpPWpGaD
Fluorouracil—Body temperature increased—Docetaxel—skin cancer	5.63e-05	0.00064	CcSEcCtD
Fluorouracil—TYMS—Circadian rythm related genes—CDK4—skin cancer	5.55e-05	0.00127	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—ERCC2—skin cancer	5.46e-05	0.00125	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—IL6—skin cancer	5.4e-05	0.00124	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Docetaxel—skin cancer	5.25e-05	0.000596	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	5.2e-05	0.00119	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PLIN2—skin cancer	5.2e-05	0.00119	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—ERCC2—skin cancer	5.07e-05	0.00116	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ERCC2—skin cancer	5.07e-05	0.00116	CbGpPWpGaD
Fluorouracil—Pruritus—Docetaxel—skin cancer	5.04e-05	0.000573	CcSEcCtD
Fluorouracil—MTHFR—Disease—CSPG4—skin cancer	5e-05	0.00114	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MLH1—skin cancer	4.93e-05	0.00113	CbGpPWpGaD
Fluorouracil—Diarrhoea—Docetaxel—skin cancer	4.87e-05	0.000554	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—skin cancer	4.71e-05	0.000535	CcSEcCtD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.65e-05	0.00107	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—skin cancer	4.62e-05	0.00106	CbGpPWpGaD
Fluorouracil—Vomiting—Docetaxel—skin cancer	4.53e-05	0.000515	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—PLIN2—skin cancer	4.52e-05	0.00104	CbGpPWpGaD
Fluorouracil—Rash—Docetaxel—skin cancer	4.49e-05	0.00051	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—skin cancer	4.49e-05	0.00051	CcSEcCtD
Fluorouracil—Headache—Docetaxel—skin cancer	4.46e-05	0.000507	CcSEcCtD
Fluorouracil—ABCC5—Disease—CSPG4—skin cancer	4.35e-05	0.000997	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ENO2—skin cancer	4.31e-05	0.000988	CbGpPWpGaD
Fluorouracil—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	4.28e-05	0.00098	CbGpPWpGaD
Fluorouracil—Nausea—Docetaxel—skin cancer	4.23e-05	0.000481	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—CSPG4—skin cancer	4.19e-05	0.000959	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.13e-05	0.000947	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PLIN2—skin cancer	4.03e-05	0.000922	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CSPG4—skin cancer	3.65e-05	0.000835	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ERCC2—skin cancer	3.52e-05	0.000805	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ERCC2—skin cancer	3.52e-05	0.000805	CbGpPWpGaD
Fluorouracil—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	3.48e-05	0.000797	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SHH—skin cancer	3.4e-05	0.000778	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ENO2—skin cancer	3.4e-05	0.000778	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PLIN2—skin cancer	3.33e-05	0.000764	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTGS2—skin cancer	3.27e-05	0.000749	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CSPG4—skin cancer	3.25e-05	0.000744	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.2e-05	0.000734	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.19e-05	0.000729	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.18e-05	0.000728	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTGS2—skin cancer	3.04e-05	0.000697	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTGS2—skin cancer	3.04e-05	0.000697	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.97e-05	0.000681	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ENO2—skin cancer	2.96e-05	0.000678	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SHH—skin cancer	2.96e-05	0.000678	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.87e-05	0.000657	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ENO2—skin cancer	2.85e-05	0.000652	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDK4—skin cancer	2.8e-05	0.000641	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TERT—skin cancer	2.8e-05	0.000641	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FOXO4—skin cancer	2.77e-05	0.000634	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.77e-05	0.000634	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	2.71e-05	0.00062	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CSPG4—skin cancer	2.69e-05	0.000615	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.61e-05	0.000597	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ERCC2—skin cancer	2.51e-05	0.000574	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDK4—skin cancer	2.5e-05	0.000573	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ENO2—skin cancer	2.48e-05	0.000567	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.47e-05	0.000567	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.46e-05	0.000563	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FOXO4—skin cancer	2.41e-05	0.000552	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—skin cancer	2.36e-05	0.000541	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PLIN2—skin cancer	2.3e-05	0.000526	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.28e-05	0.000522	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.23e-05	0.00051	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ENO2—skin cancer	2.21e-05	0.000505	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—IL6—skin cancer	2.16e-05	0.000495	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN2A—skin cancer	2.14e-05	0.00049	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.13e-05	0.000488	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTGS2—skin cancer	2.11e-05	0.000483	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTGS2—skin cancer	2.11e-05	0.000483	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PLIN2—skin cancer	2.09e-05	0.000478	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—skin cancer	2.03e-05	0.000464	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERCC2—skin cancer	1.97e-05	0.000452	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN2A—skin cancer	1.91e-05	0.000438	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL6—skin cancer	1.86e-05	0.000425	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CSPG4—skin cancer	1.85e-05	0.000424	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TERT—skin cancer	1.85e-05	0.000424	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ENO2—skin cancer	1.83e-05	0.000418	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.81e-05	0.000415	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERCC2—skin cancer	1.72e-05	0.000394	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CSPG4—skin cancer	1.68e-05	0.000386	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ERCC2—skin cancer	1.65e-05	0.000379	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TERT—skin cancer	1.61e-05	0.000369	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTGS2—skin cancer	1.5e-05	0.000344	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.47e-05	0.000338	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—BRAF—skin cancer	1.47e-05	0.000336	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ERCC2—skin cancer	1.44e-05	0.00033	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.43e-05	0.000327	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLIN2—skin cancer	1.43e-05	0.000327	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLIN2—skin cancer	1.42e-05	0.000325	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ERCC2—skin cancer	1.28e-05	0.000294	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—BRAF—skin cancer	1.28e-05	0.000292	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ENO2—skin cancer	1.26e-05	0.000288	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—skin cancer	1.18e-05	0.000271	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLIN2—skin cancer	1.16e-05	0.000266	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CSPG4—skin cancer	1.15e-05	0.000263	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—skin cancer	1.15e-05	0.000263	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ENO2—skin cancer	1.14e-05	0.000262	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CSPG4—skin cancer	1.14e-05	0.000262	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—skin cancer	1.06e-05	0.000244	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ERCC2—skin cancer	1.06e-05	0.000243	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—skin cancer	1.03e-05	0.000236	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLIN2—skin cancer	9.92e-06	0.000227	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—skin cancer	9.91e-06	0.000227	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—skin cancer	9.88e-06	0.000226	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CSPG4—skin cancer	9.36e-06	0.000214	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—skin cancer	9.21e-06	0.000211	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—skin cancer	8.78e-06	0.000201	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—skin cancer	8.63e-06	0.000198	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—skin cancer	8.4e-06	0.000192	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—skin cancer	8.02e-06	0.000184	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CSPG4—skin cancer	8e-06	0.000183	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—skin cancer	7.93e-06	0.000182	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO2—skin cancer	7.82e-06	0.000179	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO2—skin cancer	7.77e-06	0.000178	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—skin cancer	7.69e-06	0.000176	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ERCC2—skin cancer	7.32e-06	0.000168	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—skin cancer	6.9e-06	0.000158	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—skin cancer	6.74e-06	0.000154	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ERCC2—skin cancer	6.65e-06	0.000152	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—skin cancer	6.45e-06	0.000148	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—skin cancer	6.36e-06	0.000146	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—skin cancer	6.36e-06	0.000146	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.11e-06	0.00014	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.08e-06	0.000139	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—skin cancer	5.87e-06	0.000134	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—skin cancer	5.61e-06	0.000129	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—skin cancer	5.44e-06	0.000124	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—skin cancer	5.19e-06	0.000119	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.98e-06	0.000114	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ERCC2—skin cancer	4.54e-06	0.000104	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ERCC2—skin cancer	4.51e-06	0.000103	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—skin cancer	4.47e-06	0.000102	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—skin cancer	4.39e-06	0.0001	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.25e-06	9.74e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—skin cancer	3.99e-06	9.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—skin cancer	3.97e-06	9.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—skin cancer	3.8e-06	8.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ERCC2—skin cancer	3.7e-06	8.46e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ERCC2—skin cancer	3.16e-06	7.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—skin cancer	2.72e-06	6.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—skin cancer	2.71e-06	6.2e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—skin cancer	2.22e-06	5.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—skin cancer	1.89e-06	4.34e-05	CbGpPWpGaD
